Vitamin E and changes in serum alanine aminotransferase levels in patients with non‐alcoholic steatohepatitis - Hoofnagle, J. H.; Natta, M. L.; Kleiner, D. E.; Clark, J. M.; Kowdley, K. V.; Loomba, R.; Neuschwander‐Tetri, B. A.; Sanyal, A. J.; Tonascia, J. (Alimentary pharmacology & therapeutics, 2013)
Keywords: Adult; Alanine Transaminase - blood; Antioxidants - therapeutic use; Biological and medical sciences; Digestive system; Fatty Liver - drug therapy; Fatty Liver - enzymology; Female; Gastroenterology. Liver. Pancreas. Abdomen; Humans; Hypoglycemic Agents - therapeutic use; Liver. Biliary tract. Portal circulation. Exocrine pancreas; Male; Medical sciences; Middle Aged; Non-alcoholic Fatty Liver Disease; Other diseases. Semiology; Pharmacology. Drug treatments; Thiazolidinediones - therapeutic use; Vitamin E - therapeutic use; Weight Loss; Human; Biological fluid; Enzyme; Vitamin E; Transaminases; Transferases; Non alcoholic steatohepatitis; Alanine transaminase; Digestive diseases; Hepatic disease; Serum